Safety, Tolerability and Pharmacokinetics of SBC-102 (Sebelipase Alfa) in Adult Participants With Lysosomal Acid Lipase Deficiency
Clinical trial NCT01307098 · COMPLETED
Trial details
- NCT number
- NCT01307098
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-25
- Primary completion
- 2012-01-06
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.